thank you for your valuable input. glpg is already valued at 1.5Xfgen mas o menos. both are partnered with their most advanced drug and now with IPF data from both and fgen being more solid and advanced than glpg regarding IPF, is the extra MC glpg over fgen justifiable ? i have no issue with the integrity of both mgts unlike some other biotech values lol. also, fgen roxa although partnered, seems to me much more valuable potentially due to the "china factor" lol.